Early effects of acetazolamide on hemoglobin mass and plasma volume in chronic mountain sickness at 5100 m

Abstract

Short-term ACZ uptake was effective to reduce Hct in CMS-highlanders living at extreme altitude >5,000 m and was associated with both an increase in PV and a reduction in RBCV.